Etavopivat [CAS 2245053-57-8] (10mM in DMSO)
Partner: MedChemexpress LLC
CAS No: | 2245053-57-8 |
Applications: | COVID-19-immunoregulation |
MW: | 457.50 |
Formula: | C22H23N3O6S |
SMILES: | O=S(N1CC2=C(CN(C2)C([C@@H](C3=CC=CC=C3)CO)=O)C1)(C4=CN=C(OCCO5)C5=C4)=O |
Purity: | 98.70 |
Description: | Etavopivat is a potent, selective, orally bioavailable red blood cell (RBC) pyruvate kinase (PKR) activator. Etavopivat has potent antisickling effects[1]. |
Shipping Conditions: | Ship on cold packs |
Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice